Pfizer (PFE) PT Raised to $48 at BofA/Merrill Lynch Ahead of Orphan Drug Catalyst
Tweet Send to a Friend
(Updated - April 1, 2019 7:30 AM EDT)(updated to add analyst comments)BofA/Merrill Lynch analyst Jason ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
